Hansa Biopharma AB (publ) (STO:HNSA)
Sweden · Delayed Price · Currency is SEK 30.40
+0.98 (3.33%)
Mar 23, 2026, 2:00 PM CET
Hansa Biopharma AB Market Cap
Hansa Biopharma AB has a market cap or net worth of 2.99 billion as of March 23, 2026. Its market cap has increased by 90.29% in one year.
Market Cap
2.99B
Enterprise Value
3.23B
Revenue
222.27M
Ranking
n/a
PE Ratio
n/a
Stock Price
30.40
Market Cap Chart
Since April 24, 2008, Hansa Biopharma AB's market cap has increased from 30.71M to 2.99B, an increase of 9,648.12%. That is a compound annual growth rate of 29.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 2.99B | -14.38% |
| Dec 30, 2025 | 3.50B | 31.53% |
| Dec 30, 2024 | 2.66B | 93.47% |
| Dec 29, 2023 | 1.37B | -46.77% |
| Dec 30, 2022 | 2.58B | -34.64% |
| Dec 30, 2021 | 3.95B | -63.06% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Flerie AB | 2.76B |
| Vicore Pharma Holding AB | 2.67B |
| Saniona AB | 2.08B |
| Egetis Therapeutics AB | 1.97B |
| Diamyd Medical AB | 1.87B |
| BioInvent International AB | 1.43B |
| Medivir AB | 1.16B |
| Xspray Pharma AB | 1.11B |